Cardiology Devices - Bosnia and Herzegovina

  • Bosnia and Herzegovina
  • The projected revenue in the Cardiology Devices market market in Bosnia and Herzegovina is set to reach US$30.48m in 2024.
  • This is expected to exhibit an annual growth rate (CAGR 2024-2029) of 6.88%, leading to a market volume of US$42.51m by 2029.
  • In comparison to other countries worldwide, the United States is anticipated to generate the highest revenue, amounting to US$25,770.00m in 2024.
  • Bosnia and Herzegovina's cardiology device market is witnessing a surge in demand for innovative and cost-effective solutions to address the rising incidence of cardiovascular diseases in the country.

Key regions: United Kingdom, United States, France, Spain, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cardiology Devices market in Bosnia and Herzegovina is experiencing steady growth due to increasing customer preferences for advanced medical technologies and a growing number of cardiovascular diseases in the country.

Customer preferences:
Customers in Bosnia and Herzegovina are increasingly demanding advanced cardiology devices that provide accurate and efficient diagnosis and treatment of cardiovascular diseases. They prefer devices that are minimally invasive, offer quick recovery times, and provide long-term benefits. The demand for innovative technologies such as implantable cardioverter-defibrillators (ICDs), pacemakers, and cardiac monitoring devices is on the rise. Customers also value devices that are user-friendly and can be easily integrated into their daily lives.

Trends in the market:
One of the key trends in the Cardiology Devices market in Bosnia and Herzegovina is the increasing adoption of minimally invasive procedures. Patients are opting for less invasive treatment options that offer quicker recovery times and fewer complications. This trend is driving the demand for devices such as transcatheter aortic valve replacement (TAVR) systems, which allow for the replacement of the aortic valve without open-heart surgery. The market is also witnessing a shift towards remote monitoring and telemedicine solutions, which enable healthcare professionals to remotely monitor patients' cardiac health and provide timely interventions.

Local special circumstances:
Bosnia and Herzegovina has a high prevalence of cardiovascular diseases, which is contributing to the growth of the Cardiology Devices market. The country has a high smoking rate, unhealthy dietary habits, and a sedentary lifestyle, all of which are risk factors for cardiovascular diseases. Additionally, the aging population in the country is also driving the demand for cardiology devices, as the risk of cardiovascular diseases increases with age.

Underlying macroeconomic factors:
The healthcare infrastructure in Bosnia and Herzegovina is improving, with increased investments in healthcare facilities and the adoption of advanced medical technologies. The government is also focusing on healthcare reforms and initiatives to improve access to healthcare services, which is expected to drive the demand for cardiology devices. Furthermore, the country's economic growth and rising disposable income levels are enabling more individuals to afford advanced medical treatments, including cardiology devices. In conclusion, the Cardiology Devices market in Bosnia and Herzegovina is growing due to increasing customer preferences for advanced medical technologies and the high prevalence of cardiovascular diseases in the country. The demand for minimally invasive procedures, remote monitoring solutions, and user-friendly devices is driving the market growth. The local special circumstances, such as the high prevalence of cardiovascular diseases and the aging population, further contribute to the market growth. The improving healthcare infrastructure and the government's focus on healthcare reforms are also favorable macroeconomic factors for the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)